(Reuters) – Sensodyne toothpaste-maker Haleon said on Thursday it expected higher revenue in 2024, thanks to firm demand for its household products ranging from painkillers, nasal sprays and multivitamins.
Haleon said its organic revenue would rise between 4%-6% this year, as the consumer healthcare company reported its first full-year results since it was spun off from GSK in 2022.
Analysts on average expect organic revenue to grow by 4.5%, according to a company-compiled consensus.
(Reporting by Eva Mathews in Bengaluru; Editing by Subhranshu Sahu)
